Skip to content

Clinical trials

Phase 2 Vulvar Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Vulvar Neoplasms Phase: Phase 2 Clear all

48 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20051
20075
20081
20091
20101
20111
20122
20131
20151
20173
20182
20191
20204
20213
20221
20235
20246
20252
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Recruiting14
Active, not recruiting7
Unknown status5
Terminated4
Not yet recruiting2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Dana-Farber Cancer Institute3
Gynecologic Oncology Group3
Merck Sharp & Dohme LLC3
M.D. Anderson Cancer Center2
National Cancer Institute (NCI)2
Ohio State University Comprehensive Cancer Center2
AGO Research GmbH1
Akeso1
Baylor College of Medicine1
Beijing Health Guard Biotechnology, Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Vulvar Neoplasms48
Uterine Cervical Neoplasms29
Vaginal Neoplasms24
Endometrial Neoplasms12
Anus Neoplasms10
Ovarian Neoplasms9
Carcinoma, Ovarian Epithelial6
Fallopian Tube Neoplasms6
Neoplasm Metastasis5
Neoplasms5

Trials

Showing 51 to 48 of 48. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.